Synaptic Medical has raised about $60 million in its Series G round of funding led by Huagai Capital. In a separate development, Gemii Technology has raised nearly $30 million in its Series B round of financing.
Synaptic Medical raises funding led by Huagai Capital
US-based medical devices manufacturer Synaptic Medical has completed raising about $60 million in its Series G round led by Huagai Capital, a Chinese PE firm that invests in TMT, medical and cultural industries.
The round also saw the participation of YuanBio Venture Capital. Returning investor SIG Capital also made a follow-on investment, per a company statement issued on Friday. Investment bank Haoyue Capital facilitated the transaction.
Set up in 2015, Synaptic Medical delivers innovative medical instruments for treatments in areas of cardiovascular diseases. Its products are widely used across 800 hospitals in China.
Shunwei backs Gemii
Gemii Technology, a provider of social marketing and new retail services, has garnered about $30 million in its Series B round led by Trustbridge Partners, a Shanghai-based investment firm that has backed industry giants like WeWork, Dianping, and Yuanfudao.
Shunwei Capital and Matrix Partners China, which had jointly invested $10 million in Gemii’s Series A round in 2018, also re-upped in the round. Investment bank 100Summit Partners served as the exclusive financial advisor for the deal, the company said in a WeChat post.
Proceeds from the round will be used to level up technology innovations and digital marketing services.
Since its inception in 2016 in Shanghai, Gemii claims to have helped nearly 100 brands such as Danone, Nespresso, and Sam’s Club to drive sales.